TWI365744B - Combinations of a pyrimidine containing nnrti with rt inhibitors - Google Patents

Combinations of a pyrimidine containing nnrti with rt inhibitors

Info

Publication number
TWI365744B
TWI365744B TW093126446A TW93126446A TWI365744B TW I365744 B TWI365744 B TW I365744B TW 093126446 A TW093126446 A TW 093126446A TW 93126446 A TW93126446 A TW 93126446A TW I365744 B TWI365744 B TW I365744B
Authority
TW
Taiwan
Prior art keywords
inhibitors
combinations
pyrimidine containing
nnrti
containing nnrti
Prior art date
Application number
TW093126446A
Other languages
English (en)
Chinese (zh)
Other versions
TW200524612A (en
Inventor
Paul Stoffels
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43778148&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TWI365744(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of TW200524612A publication Critical patent/TW200524612A/zh
Application granted granted Critical
Publication of TWI365744B publication Critical patent/TWI365744B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW093126446A 2003-09-03 2004-09-02 Combinations of a pyrimidine containing nnrti with rt inhibitors TWI365744B (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US49977103P 2003-09-03 2003-09-03
EP03103275 2003-09-03
EP03103319 2003-09-08
EP03103335 2003-09-10
EP03103668 2003-10-02
US50848603P 2003-10-03 2003-10-03

Publications (2)

Publication Number Publication Date
TW200524612A TW200524612A (en) 2005-08-01
TWI365744B true TWI365744B (en) 2012-06-11

Family

ID=43778148

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093126446A TWI365744B (en) 2003-09-03 2004-09-02 Combinations of a pyrimidine containing nnrti with rt inhibitors

Country Status (9)

Country Link
KR (2) KR101638999B1 (es)
CN (1) CN102319433A (es)
DK (1) DK1663240T4 (es)
EA (1) EA014840B1 (es)
ES (1) ES2542017T5 (es)
HU (1) HUE025576T2 (es)
PT (1) PT1663240E (es)
SI (1) SI1663240T2 (es)
TW (1) TWI365744B (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3429B1 (ar) * 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv مشتقات برميدينات مثبطة فيروس الايدز

Also Published As

Publication number Publication date
HUE025576T2 (en) 2016-04-28
CN102319433A (zh) 2012-01-18
KR101638999B1 (ko) 2016-07-12
DK1663240T4 (da) 2023-04-17
KR20130127515A (ko) 2013-11-22
ES2542017T3 (es) 2015-07-29
SI1663240T2 (sl) 2023-05-31
DK1663240T3 (en) 2015-07-20
KR20110132475A (ko) 2011-12-07
SI1663240T1 (sl) 2015-10-30
PT1663240E (pt) 2015-09-01
KR101539245B1 (ko) 2015-07-27
EA200600522A1 (ru) 2006-08-25
EA014840B1 (ru) 2011-02-28
ES2542017T5 (es) 2023-06-15
TW200524612A (en) 2005-08-01

Similar Documents

Publication Publication Date Title
HUS1600058I1 (hu) Pirimidin-tartalmú NNRTI kombinációi RT inhibitorokkal
IL175123A0 (en) Crystalline ammonium salts of rosuvastatin
AU2003251559A8 (en) Heterocyclic inhibitors of kinases
SG153875A1 (en) Pyrimidine urea derivatives as kinase inhibitors
HK1072545A1 (en) Novel inhibitors of kinases
PT1763517E (pt) Derivados de pirimidina como inibidores 11beta-hsd1
PL378116A1 (pl) Heterocykliczne inhibitory kinazy
TWI365744B (en) Combinations of a pyrimidine containing nnrti with rt inhibitors
AU153741S (en) Watch holder
GB0422587D0 (en) Cartridge holder
ZA200609510B (en) Pyrimidine urea derivatives as kinase inhibitors
ZA200500492B (en) Novel inhibitors of kinases